TransThera Sciences Nanjing, Inc. (the "TransThera") announced that the new drug application for Tinengotinib tablets has been accepted by the Center for Drug Evaluation ("CDE")of the National Medical ...

The latest update is out from TransThera Sciences (Nanjing). Inc. ( (HK:2617) ).

Gallbladder cancer and cholangiocarcinoma are different types of biliary tract cancer. They affect the same system in the body and cause similar symptoms, but they may require different treatments.

Curtis Jackson was feeling fit and healthy in late 2020 when he decided to update his life insurance policy: He was in better shape than he'd been in a while, but he wanted to make sure his wife and ...

Cindy and Katie share how caring for parents with cholangiocarcinoma led to friendship, support and advocacy through the Cholangiocarcinoma Foundation. While the FDA approval of Truseltiq for ...

Cholangiocarcinomas are a diverse group of tumors that are presumed to originate from the biliary tract epithelium either within the liver or the biliary tract. These cancers are often difficult to ...

After he died in June from cancer, his wife started a research scholarship in his honor, which will hold a fundraising event ...

Stacie C. Lindsey is being recognized for her patient advocacy, alignment of research efforts and collaboration among the cancer community. AstraZeneca and Scientific American Custom Media sponsor the ...

Genfit has announced encouraging preliminary results from its phase 1b clinical trial evaluating investigational drug GNS561 in combination with a MEK inhibitor (MEKi) in patients with KRAS mutated ...